These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17725522)

  • 1. A key glycolytic enzyme plays a dual role in GABAergic neurotransmission and in human epilepsy.
    Pumain R; Laschet J
    Crit Rev Neurobiol; 2006; 18(1-2):197-203. PubMed ID: 17725522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of GABAA receptor glycolysis-dependent modulation in human partial epilepsy.
    Laschet JJ; Kurcewicz I; Minier F; Trottier S; Khallou-Laschet J; Louvel J; Gigout S; Turak B; Biraben A; Scarabin JM; Devaux B; Chauvel P; Pumain R
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3472-7. PubMed ID: 17360668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lability of GABAA receptor function in human partial epilepsy: possible relationship to hypometabolism.
    Pumain R; Ahmed MS; Kurcewicz I; Trottier S; Louvel J; Turak B; Devaux B; Laschet J
    Epilepsia; 2008 Nov; 49 Suppl 8():87-90. PubMed ID: 19049598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyceraldehyde-3-phosphate dehydrogenase is a GABAA receptor kinase linking glycolysis to neuronal inhibition.
    Laschet JJ; Minier F; Kurcewicz I; Bureau MH; Trottier S; Jeanneteau F; Griffon N; Samyn B; Van Beeumen J; Louvel J; Sokoloff P; Pumain R
    J Neurosci; 2004 Sep; 24(35):7614-22. PubMed ID: 15342727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dual role for the glycolytic enzyme GAPDH in GABAergic neurotransmission and in human epilepsy].
    Laschet J; Pumain R
    Med Sci (Paris); 2007; 23(8-9):687-9. PubMed ID: 17875279
    [No Abstract]   [Full Text] [Related]  

  • 6. New therapeutic targets to develop molecules active in drug-resistant epilepsies.
    SidAhmed-Mezi M; Pumain R; Louvel J; Sokoloff P; Laschet J
    Epilepsia; 2010 Jul; 51 Suppl 3():43-7. PubMed ID: 20618399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric detection and characterization of atypical membrane-bound zinc-sensitive phosphatases modulating GABAA receptors.
    SidAhmed-Mezi M; Kurcewicz I; Rose C; Louvel J; Sokoloff P; Pumain R; Laschet JJ
    PLoS One; 2014; 9(6):e100612. PubMed ID: 24967814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures beget seizures: the quest for GABA as a key player.
    Ben-Ari Y
    Crit Rev Neurobiol; 2006; 18(1-2):135-44. PubMed ID: 17725516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of different proteins with GABAA receptor and their modulatory effect on inhibitory neural transmission leads to epilepsy.
    Faheem M; Chaudhary AG; Kumosani TA; Al-Qahtani MH; Yasir M; Bibi F; Kim MO; Rasool M; Naseer MI
    CNS Neurol Disord Drug Targets; 2014; 13(7):1148-59. PubMed ID: 25230226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three brief epileptic seizures reduce inhibitory synaptic currents, GABA(A) currents, and GABA(A)-receptor subunits.
    Evans MS; Cady CJ; Disney KE; Yang L; Laguardia JJ
    Epilepsia; 2006 Oct; 47(10):1655-64. PubMed ID: 17054688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebal overinhibition could be the basis for the high prevalence of epilepsy in persons with Down syndrome.
    Araujo BH; Torres LB; Guilhoto LM
    Epilepsy Behav; 2015 Dec; 53():120-5. PubMed ID: 26558714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and neurochemical substrates of the audiogenic seizure strains: The GASH:Sal model.
    Prieto-Martín AI; Aroca-Aguilar JD; Sánchez-Sánchez F; Muñoz LJ; López DE; Escribano J; de Cabo C
    Epilepsy Behav; 2017 Jun; 71(Pt B):218-225. PubMed ID: 26071997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-edged GABAergic synaptic transmission in seizures: The importance of chloride plasticity.
    Wang Y; Wang Y; Chen Z
    Brain Res; 2018 Dec; 1701():126-136. PubMed ID: 30201259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Regulation of GABAergic Neurotransmission and Neurosteroid Biosynthesis in Alcohol Use Disorder.
    Gatta E; Guidotti A; Saudagar V; Grayson DR; Aspesi D; Pandey SC; Pinna G
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):130-141. PubMed ID: 32968808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-kinase anchoring protein 79/150 facilitates the phosphorylation of GABA(A) receptors by cAMP-dependent protein kinase via selective interaction with receptor beta subunits.
    Brandon NJ; Jovanovic JN; Colledge M; Kittler JT; Brandon JM; Scott JD; Moss SJ
    Mol Cell Neurosci; 2003 Jan; 22(1):87-97. PubMed ID: 12595241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The neurochemistry of epilepsy, inhibitory neurotransmission and experimental models: new perspectives].
    de Cabo-de la Vega C; Villanueva-Hernández P; Prieto-Martín A
    Rev Neurol; 2006 Feb 1-15; 42(3):159-68. PubMed ID: 16475138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered thalamic GABAA-receptor subunit expression in the stargazer mouse model of absence epilepsy.
    Seo S; Leitch B
    Epilepsia; 2014 Feb; 55(2):224-32. PubMed ID: 24417662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [GABAergic mechanisms in generalized epilepsies: the neuroanatomical dimension].
    Depaulis A; Deransart C; Vergnes M; Marescaux C
    Rev Neurol (Paris); 1997; 153 Suppl 1():S8-13. PubMed ID: 9686242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shunting and hyperpolarizing GABAergic inhibition in the high-potassium model of ictogenesis in the developing rat hippocampus.
    Isaev D; Isaeva E; Khazipov R; Holmes GL
    Hippocampus; 2007; 17(3):210-9. PubMed ID: 17294460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of GABA-mediated synaptic transmission in human epilepsy.
    Lloyd KG; Bossi L; Morselli PL; Munari C; Rougier M; Loiseau H
    Adv Neurol; 1986; 44():1033-44. PubMed ID: 3010675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.